Dasatinib induces complete remission in a patient with primary cerebral involvement of B-cell chronic lymphocytic leukemia failing chemotherapy
2010
To the editor:
Primary symptomatic central nervous system (CNS) involvement as the initial manifestation of chronic lymphocytic leukemia (CLL) is exceedingly rare.[1][1] Treatment options in patients resistant to high-dose cytarabine or methotrexate chemotherapy are limited. Dasatinib is a tyrosine
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
6
References
13
Citations
NaN
KQI